- Holidays Announcement -
１）Orders received (with payment received) between 7/22 to 7/25 will be dispatched accordingly from 7/26
２）Orders received (with payment received) between 8/7 to 8/16 will be dispatched accordingly from 8/17
Saisei Pharma is conducting clinical trials of oral MAF in COVID-19 patients. Details are featured in Press Releases on some websites. Please check the links below:
-Counterfeit products warning-
3rd Generation GcMAF was developed by Saisei Pharma for which we hold patents. There are fake GcMAF products sold online in Australia by a company which is registered in Hong Kong. Please be aware that 3rd Generation GcMAF products are only produced by Saisei Pharma. Any other products from other companies are fake products.
Unverified seller alert
We were informed that a company calling themselves "Japan Health" with the websites bio-japan.net and japan-health.net is claiming to be selling our products. This seller is unverified and we have never sold our products to them. Especially our Second Generation GcMAF vials are only sold from Saisei Mirai Clinics in Japan and we do not authorize anyone to re-sell them unless they are registered as a Medical Doctor with us and prescribing them to patients. We recommend ordering GcMAF only from a trusted and reliable source. If you are unsure of the source, please contact us to confirm.
Due to Covid-19 outbreaks, EMS has announced that they have suspended services to some countries from their available destinations. For customers who have placed orders before this notice, we will proceed with a refund. Please accept our apologies for the inconvenience.
We are pleased to announce that EMS has resumed its service to the United States of America.
Please check the latest information and the list of affected countries from the link below.
FedEx Priority may be an alternative shipping option for some countries. If you wish to use FedEx Priority, please check that your country is on their list of delivery service and then add Option FedEx Priority to your cart.